As of Oct 09
| -0.019 / -2.19%|
The 2 analysts offering 12-month price forecasts for DelMar Pharmaceuticals Inc have a median target of 4.26, with a high estimate of 4.53 and a low estimate of 4.00. The median estimate represents a +401.76% increase from the last price of 0.85.
The current consensus among 1 polled investment analysts is to Buy stock in DelMar Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.